EyePoint Pharmaceuticals to Highlight DURAVYU (Vorolanib) Clinical Progress
26 Jun 2024 //
GLOBENEWSWIRE
EyePoint Shows Updated Positive Interim Data from Phase 1 Trial of EYP-1901
12 Feb 2022 //
PRNEWSWIRE
EyePoint Reports +ve Interim Safety & Efficacy Data from EYP-1901 Phase 1 Trial
14 Nov 2021 //
PIPELINEREVIEW